Research Article
Abnormally Expressed lncRNAs as Potential Biomarkers for Gastric Cancer Risk: A Diagnostic Meta-Bioinformatics Analysis
Table 6
Diagnostic efficacy of the combined model for GC with different stages.
| Stage | SEN | SPE | YI | Cut-off | AUC | (95% CI) | | value |
| I | 0.902 | 0.937 | 0.840 | 0.4114 | 0.947 | (0.875-0.984) | | | II | 0.929 | 0.938 | 0.866 | 0.5183 | 0.966 | (0.922-0.989) | -0.703 | 0.482 | III | 0.973 | 0.938 | 0.910 | 0.4553 | 0.984 | (0.952-0.997) | -1.504 | 0.133 | IV | 0.974 | 1 | 0.974 | 0.4548 | 0.998 | (0.945-1.000) | -2.183 | 0.029 | II+III+IV | 0.953 | 0.938 | 0.891 | 0.6899 | 0.977 | (0.955-0.991) | -1.192 | 0.233 |
|
|
value: -test testing AUC differences of GC different stages which all compared to stage I. |